Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.
Beskrivning
In this issue of Cardiology Clinics, guest editors Drs. Silvi Shah and Janani Rangaswami bring their considerable expertise to the topic of Cardio-Kidney-Metabolic Disorder. Top experts discuss key topics such as definition, staging, risk assessment, and therapeutic considerations; sex difference in CVD with kidney disease; obesity and CKM health: ethnicity-based risk and clinical considerations; SGLT2i across the spectrum of CKM health; and more.
Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic ConsiderationsNonatherosclerotic Cardiovascular Disease in Chronic Kidney DiseaseSex Differences in Cardiovascular Diseases and Vascular Function in Chronic Kidney DiseaseObesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical ConsiderationsSodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic SyndromeRole of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/ Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) ConditionsAtherosclerotic Cardiovascular Disease in Cardiovascular-Kidney-Metabolic SyndromeKidney Transplant and Cardiovascular-Kidney-Metabolic HealthLong-Term Cardio-Renal-Metabolic Complications Following Pre-eclampsiaA Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic SyndromeCardio-Kidney Metabolic Health in Pediatrics and Primordial PreventionHistory and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease